One method is to hope that the plaintiffs die:
Wall Street now believes Merck’s ultimate Vioxx liability is closer to $5 billion than $25 billion, Lehman Brothers analyst Tony Butler adds. The reasoning – with fewer than 20 lawsuits so far making it to trial, some plaintiffs won’t live long enough to see any money.
Related posts:
- A jury of "uneducated casino workers" beat the hell out of Merck
- Merck sends in the B-team for a physician expert witness
- Vioxx plaintiff faces a choice
- How tort reform can stimulate the economy
- Bring Vioxx back?
- Avandia: WSJ cries politics
- Reasons not to become a doctor
KevinMD.com on Facebook
Comments on this entry are closed.